Exploration of the efficacy and impact of using different concentrations of ropivacaine in clinical anesthesia and pain treatment
临床麻醉及疼痛治疗中应用不同浓度罗哌卡因的疗效及影响探讨

摘要

目的 分析在临床麻醉及疼痛治疗患者中实施025%浓度以及0.2%浓度的罗哌卡因注射的疗效。方法 将2023年1月-2024年12月内就诊的接受麻醉的100患者以入院顺序分50例对照组0.25%罗哌卡因注射，50例观察组实施0.2%浓度罗哌卡因注射，在对比麻醉效果、术前麻醉后30min的应激反应。结果 麻醉阻滞起效时间、术前应激反应无差异，但观察组在感觉阻滞恢复、运动组阻滞恢复更优且麻醉后30min后观察组应激情况指标更低，对比有统计学意义，（P<0.05），结论 0.2%浓度罗哌卡因麻醉价值更高，患者应激水平低，麻醉恢复更快，对躯体影响更小。

Abstract

Objective To analyze the efficacy of ropivacaine injection at concentrations of 0.25% and 0.2% in clinical anesthesia and pain treatment patients.
Methods 100 patients who received anesthesia from January 2023 to December 2024 were divided into a control group of 50 patients who received 0.25% ropivacaine injection and an observation group of 50 patients who received 0.2% concentration ropivacaine injection in order of admission. The anesthesia effect and stress response 30 minutes after preoperative anesthesia were compared.
Results There was no difference in the onset time of anesthesia block and preoperative stress response, but the observation group showed better recovery in sensory block and exercise block, and the stress indicators in the observation group were lower 30 minutes after anesthesia. The comparison was statistically significant, (P<0.05),
Conclusion   0.2% concentration ropivacaine has higher anesthetic value, lower patient stress levels, faster recovery from anesthesia, and less impact on the body.